Abstract: An object of the present invention is to provide a set capable of conveniently and rapidly confirming the presence or absence of contamination of a container for a test sample, the set comprising a positive control nucleic acid and a probe specific for the positive control nucleic acid. Another object of the present invention is to provide a method for detecting or quantifying a target nucleic acid in a test sample while conveniently and rapidly confirming the presence or absence of contamination of a container for the test sample with a positive control nucleic acid.

Abstract: According to one embodiment, a battery module includes a plurality of batteries and a module housing. The module housing accommodates the plurality of batteries. The module housing is configured by connecting a plurality of cases in a first direction. At least one of the plurality of cases includes a vacuum pad adsorption region which is on an end surface in a second direction intersecting the first direction and on which a vacuum pad is adsorbable.

Abstract: An outer handle device for a vehicle door, in which a supporting arm portion provided on one end portion of an operating handle which houses an electronic component unit and is disposed on an outer side of the vehicle door is turnably supported by a base member fixed to the vehicle door, a groove housing part of a harness connected to the electronic component unit and routed from the operating handle into the vehicle door is provided in the supporting arm portion, and a guide portion holding the harness between the guide portion and the supporting arm portion is disposed to cover part of the groove, wherein the guide portion is formed integrally on the base member. Accordingly, the outer handle device can hold a harness while reducing the number of components.

Abstract: An outer handle device for a vehicle door includes: a latch mechanism; an outer handle having a grip and a coupling arm that is consecutively provided at the other end of the grip and is coupled to the latch mechanism; a base member that is made of a synthetic resin and arranged on the outer side of the outer panel; a metallic reinforcing plate that is interposed between the base member and an outer surface of the outer panel; a cylinder lock configured to switch between locked and unlocked states of the vehicle door, that is disposed in the base member; and a receiving portion that is provided in the reinforcing plate and abuts against the coupling arm during a turning operation of the outer handle to an opening side of the vehicle door to restrict a turning end of the outer handle.

Abstract: An outer handle device for a vehicle door includes: a latch mechanism; an outer handle having a grip and a coupling arm that is consecutively provided at the other end of the grip and is coupled to the latch mechanism; a base member that is made of a synthetic resin and arranged on the outer side of the outer panel; a metallic reinforcing plate that is interposed between the base member and an outer surface of the outer panel; a cylinder lock configured to switch between locked and unlocked states of the vehicle door, that is disposed in the base member; and a receiving portion that is provided in the reinforcing plate and abuts against the coupling arm during a turning operation of the outer handle to an opening side of the vehicle door to restrict a turning end of the outer handle.

Abstract: An outer handle device for a vehicle door, in which a supporting arm portion provided on one end portion of an operating handle which houses an electronic component unit and is disposed on an outer side of the vehicle door is turnably supported by a base member fixed to the vehicle door, a groove housing part of a harness connected to the electronic component unit and routed from the operating handle into the vehicle door is provided in the supporting arm portion, and a guide portion holding the harness between the guide portion and the supporting arm portion is disposed to cover part of the groove, wherein the guide portion is formed integrally on the base member. Accordingly, the outer handle device can hold a harness while reducing the number of components.

Abstract: HLA matched activated lymphocytes in mononuclear cells separated from peripheral blood or umbilical cord blood are proliferated and activated. After separating and collecting, the HLA matched activated lymphocytes are employed as the main component of a composition for promoting survival of transplanted hematopoietic stem cells. The obtained composition is widely usable in, for instance, prevention of survival failure of transplanted hematopoietic stem cells and therapy for promoting the survival thereof. Although the dose of the composition varies depending on the age, conditions, etc. of a patient, a humanized antibody is administered in a dose of from 0.2 to 20 ml/kg/day to mammals including humans. The composition is administered by intravenous injection either once a day (single administration or continuous administration) or intermittently once to 3 times in a week or once in 2 or 3 weeks.

Abstract: A power supply connector is provided, which is applicable to both large current charging and low current charging, the power supply connector being able to not only maintain the accuracy of monitoring low current charging and the volumetric efficiency of a board by appropriately arranging two types of connector parts, but also contribute to the downsizing of the power supply connector and improvement of the reliability thereof by striking a balance between the volumetric efficiency and the heat radiation characteristics, and ensure safety in the use of the power supply connector while reducing the cost. Insertion holes 4 and connector pins 2 that configure a large current charging connector part are disposed in the vicinity of both ends of the power supply connector 1. There are disposed a plug insertion hole 9 and low current charging connector pins 11 that configure a low current charging connector part held between the insertion holes 4 and the connector pins 2.

Abstract: HLA matched activated lymphocytes in mononuclear cells separated from peripheral blood or umbilical cord blood are proliferated and activated. After separating and collecting, the HLA matched activated lymphocytes are employed as the main component of a composition for promoting survival of transplanted hematopoietic stem cells. The obtained composition is widely usable in, for instance, prevention of survival failure of transplanted hematopoietic stem cells and therapy for promoting the survival thereof. Although the dose of the composition varies depending on the age, conditions, etc. of a patient, a humanized antibody is administered in a dose of from 0.2 to 20 ml/kg/day to mammals including humans. The composition is administered by intravenous injection either once a day (single administration or continuous administration) or intermittently once to 3 times in a week or once in 2 or 3 weeks.

Abstract: A power supply connector is provided, which is applicable to both large current charging and low current charging, the power supply connector being able to not only maintain the accuracy of monitoring low current charging and the volumetric efficiency of a board by appropriately arranging two types of connector parts, but also contribute to the downsizing of the power supply connector and improvement of the reliability thereof by striking a balance between the volumetric efficiency and the heat radiation characteristics, and ensure safety in the use of the power supply connector while reducing the cost. Insertion holes 4 and connector pins 2 that configure a large current charging connector part are disposed in the vicinity of both ends of the power supply connector 1. There are disposed a plug insertion hole 9 and low current charging connector pins 11 that configure a low current charging connector part held between the insertion holes 4 and the connector pins 2.

Abstract: A battery pack is provided, in which external connection terminals are arrayed in the same direction in the module having the plurality of cells connected in series and a wiring that cuts across the module is not generated, and, in which improvement of the workability and reduction of connection failures are achieved by only connecting between the units by means of a bus bar when creating the module. Three pieces of flat-plate cells 2a to 2c are arranged in parallel to configure a three-piece unit 1. A positive electrode terminal 3 and negative electrode terminal 4 are provided at the top of each of the cells 2a to 2c.

Abstract: An object of the present invention is to provide a method for treating defects of articular cartilage or meniscus of a patient using in vivo chondrogenesis of synovium-derived MSCs. The present invention provides a method for treating a disease associated with defects of cartilage or meniscus. In the present invention, the method for treating a disease associated with defects of cartilage or meniscus comprises the following steps: culturing ex vivo autologous synovium-derived mesenchymal stem cells (MSCs); implanting the MSCs such that said cartilage defect site or meniscal defect site is covered by the MSCs; and regenerating cartilage tissue at the cartilage defect site or meniscal defect site in situ by differentiating the MSCs into cartilage cells.

Abstract: HLA matched activated lymphocytes in mononuclear cells separated from peripheral blood or umbilical cord blood are proliferated and activated. After separating and collecting, the HLA matched activated lymphocytes are employed as the main component of a composition for promoting survival of transplanted hematopoietic stem cells. The obtained composition is widely usable in, for instance, prevention of survival failure of transplanted hematopoietic stem cells and therapy for promoting the survival thereof. Although the dose of the composition varies depending on the age, conditions, etc. of a patient, a humanized antibody is administered in a dose of from 0.2 to 20 ml/kg/day to mammals including humans. The composition is administered by intravenous injection either once a day (single administration or continuous administration) or intermittently once to 3 times in a week or once in 2 or 3 weeks.

Abstract: According to the present invention, HLA matching donor-originating activated lymphocytes highly effective in the treatment of patients with tumors, viral infections and autoimmune diseases are prepared by collecting cells contained in peripheral blood originating from an HLA matching donor or peripheral blood originating from an HLA matching donor achieving micro-chimerism and by stimulating and propagating the cells thus collected with, for instance, interleukin 2 and anti-CD3 antibodies or the like. The HLA matching donor-originating activated lymphocytes thus prepared can be administered to an HLA matching patient with a tumor, a viral infection or an autoimmune disease for therapeutic or preventive purposes.

Abstract: The radius of curvature of an outer surface of a panel useful portion is 10,000 mm or more. Assuming that a length of a perforated region of a shadow mask in an X-axis (major axis) direction is 2L, s is a variable satisfying 0<s<1, a sagging amount difference of the perforated region at a point of X=sL with respect to a point of X=0 on the X axis and a sagging amount difference of the perforated region at a point of X=L with respect to the point of X=sL on the X axis are ?Z01(s) and ?Z02(s), respectively, a sagging amount difference of the perforated region at the point of X=sL with respect to the point of X=0 on the long side and a sagging amount difference of the perforated region at the point of X=L with respect to the point of X=sL on the long side are ?Z11(s) and ?Z12(s), respectively, when ?(s) represented by ?(s)=(?Z01(s)/?Z11(s))/(?Z02(s)/?Z12(s)) is defined, d?(s)/ds?0.4 is satisfied in at least a portion in a range of 0.2?s?0.8.

Abstract: [PROBLEMS] To stabilize the survival of transplanted hematopoietic stem cells by using HLA identical activated lymphocytes. [MEANS FOR RESOLVING PROBLEMS] HLA identical activated lymphocytes in mononuclear cells separated from peripheral blood or umbilical cord blood are proliferated and activated. After separating and collecting, the HLA identical activated lymphocytes are employed as the main component of a composition for promoting survival of transplanted hematopoietic stem cells. The obtained composition is widely usable in, for instance, prevention of survival failure of transplanted hematopoietic stem cells and therapy for promoting the survival thereof. Although the dose of the composition varies depending on the age, conditions, etc. of a patient, a humanized antibody is administered in a dose of from 0.2 to 20 ml/kg/day to mammals including humans.

Abstract: The radius of curvature of the outer surface of a panel is 10,000 mm or more, and a shadow mask is made of a material containing 95% or more of iron. A sagging amount change curve along a curve C1 on the surface of the shadow mask, which a plane passing through a center P0 of a useful area of the shadow mask and parallel to a tube axis and a major axis crosses, satisfies a particular Condition 1. Assuming that an intersection between the curve C1 and a useful area end of the shadow mask is a major axis end PL, a distance from the center P0 to the major axis end PL along a major axis is W, and a point on the curve C1 away from the center P0 by ?×W in the major axis direction is P1, a sagging amount change curve along a curve C2 on the surface of the shadow mask, which a plane passing through the point P1 and parallel to the tube axis and the minor axis crosses, satisfies a particular Condition 2.

Abstract: The radius of curvature of an outer surface of a useful portion of a panel is 10,000 mm or more, and a shadow mask is made of a material containing 95% or more of iron. Assuming that a distance (unit: mm) along an X-axis between a center of the panel and a peripheral edge of the useful portion is LH, and a total number of rows of apertures composed of electron beam passage apertures arranged on a straight line substantially parallel to a Y-axis is N, 0.9?LH/N?1.0 is satisfied. Furthermore, assuming that a pitch of adjacent rows of apertures is PHC at a center of a perforated region of the shadow mask, PHH at a major axis end of the perforated region, and PHM at a point away from the center of the perforated region by 2/3 of a distance MH between the center of the perforated region and the major axis end along the X-axis, PHM/PHC?1.2 and PHH/PHC?1.4 are satisfied.

Abstract: The mask body satisfies the following conditions, (ZMD?ZMH)/LMS?0.020, and 0.065?ZMD/LMD?0.095 where in a substantially rectangular effective region with a predetermined curvature of the mask body, LMD is a distance between a central part and a diagonal-axis end of the effective region, LMS is a distance between a horizontal-axis end and the diagonal-axis end of the effective region, ZMD is a height difference between the central part and the diagonal-axis end in a direction of the tube axis, and ZMH is a height difference between the central part and the horizontal-axis end in the direction of the tube axis. With this structure, the mechanical strength of the mask body can be improved, and deformation of the mask body in a fabrication process and due to external shock can be prevented.

Abstract: The radius of curvature of an outer surface of a panel useful portion is 10,000 mm or more. Assuming that a length of a perforated region of a shadow mask in an X-axis (major axis) direction is 2L, s is a variable satisfying 0<s<1, a sagging amount difference of the useful portion at a point of X=sL with respect to a point of X=0 on the X axis and a sagging amount difference of the perforated region at a point of X=L with respect to the point of X=sL on the X axis are ?Z01(s) and ?Z02(s), respectively, a sagging amount difference of the useful portion at the point of X=sL with respect to the point of X=0 on the long side and a sagging amount difference of the perforated region at the point of X=L with respect to the point of X=sL on the long side are ?Z11(s) and ?Z12(s), respectively, when ?(s) represented by ?(s)=(?Z01(s)/?Z11(s))/(?Z02(s)/?Z12(s)) is defined, d?(s)/ds?0.4 is satisfied in at least a portion in a range of 0.2?s?0.8.